title: MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
authors.forename: R W
authors.initials: RW
authors.lastname: Stam
authors.forename: I
authors.initials: I
authors.lastname: Hubeek
authors.forename: M L
authors.initials: ML
authors.lastname: den Boer
authors.forename: J G C A M
authors.initials: JG
authors.lastname: Buijs-Gladdines
authors.forename: U
authors.initials: U
authors.lastname: Creutzig
authors.forename: G J L
authors.initials: GJ
authors.lastname: Kaspers
authors.forename: R
authors.initials: R
authors.lastname: Pieters
mesh_terms: D049109:Cell Proliferation / Q000187:drug effects; D003561:Cytarabine / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D004354:Drug Screening Assays, Antitumor; D015321:Gene Rearrangement; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D066298:In Vitro Techniques; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy*; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D008954:Models, Biological; D051788:Myeloid-Lymphoid Leukemia Protein / Q000187:drug effects / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: C497422:KMT2A protein, human; D003561:Cytarabine; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase